Biotechnology company
Complement Therapeutics has raised €72M across 1 funding round from 7 investors, most recently a Series A round in Apr 2023. Based in Munich, Germany; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-17 | Series A |
| €72M |
| BioGeneration Ventures,Cambridge Innovation Capital,Forbion,Gimv,Hadean Ventures,Panakès Partners+1 more |
| View deal → |
